<SUBMISSION>
<SECRELEASE-DATETIME> 20151203-163134 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20151203-163134 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20151203-163029 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001493152-15-006033
<TYPE> 8-K
<PUBLIC-DOCUMENT-COUNT> 2
<PERIOD> 20151202
<ITEMS> 1.01
<ITEMS> 5.02
<ITEMS> 9.01
<FILING-DATE> 20151203
<DATE-OF-FILING-DATE-CHANGE> 20151203
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> Akers Biosciences Inc
<CIK> 0001321834
<ASSIGNED-SIC> 2835
<IRS-NUMBER> 000000000
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 8-K
<ACT> 34
<FILE-NUMBER> 001-36268
<FILM-NUMBER> 151267709
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 201 GROVE RD
<CITY> THOROFARE
<STATE> NJ
<ZIP> 08086
<PHONE> 856-848-8698
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 201 GROVE RD
<CITY> THOROFARE
<STATE> NJ
<ZIP> 08086
</MAIL-ADDRESS>
</FILER>
|
<DOCUMENT>
<TYPE> 8-K
<SEQUENCE> 1
<FILENAME> form8-k.htm
<TEXT>
<HTML>
Show <HTML>: 374 lines (widest: 373 characters) - 35K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-10.1
<SEQUENCE> 2
<FILENAME> ex10-1.htm
<TEXT>
<HTML>
Show <HTML>: 640 lines (widest: 373 characters) - 67K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
